Cyclacel Pharmaceuticals Inc. 6% Convertible Preferred Stock

(CYCCP) Trade

By |

Profile

Cyclacel Pharmaceuticals Inc mainly develops targeted medicines for cancer and other proliferative diseases. The company focuses in hematology and oncology-based development pipeline of novel drug candidates.

Contact Information

Website: www.cyclacel.com
Email: ir@cyclacel.com
Main Phone: +1 908 517-7330
Address: 200 Connell Drive
Address 2: Suite 1500
State: NJ
City / Town: Berkeley Heights
Country: USA
Postal Code: 07922

Issuer Information

Exchange: NSC
CEO: Spiro Rombotis
Employees: 12
NAICS: Pharmaceutical Preparation Manufacturing (325412)
$ 6.52 $ 0.12 (1.88%)
Last Price 6.52 Change $ 0.12 Change % 1.88 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 6.55 High 6.55 Low 6.52 Prev Close 6.40
Last Trade Volume 235 52 Wk Hi 8.75 52 Wk Low 5.11
Market Cap 2.2 mi Ex-Div Date Div Rate 0.60 Yield 9.2020
Shares 335,273.00 EPS (TTM) N/A PE Ratio N/A Exchange NCM